India Share Brokers | Equity Trading India | Derivative Trading in India | Share Brokers in India

Markets Navigation

Company Info.

Cohance Lifesciences Ltd.

Income Statement - Consolidated

Market Cap.(`)	27579.57 Cr.	P/BV	13.94	Book Value (`)	77.71
52 Week High/Low ( ` )	1360/598	FV/ML	1/1	P/E(X)	91.85
Book Closure	09/08/2024	EPS (`)	11.80	Div Yield (%)	0.00

(` in Crs.)

You can view the Consolidated Income Statement for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00


INCOME
Revenue From Operations [Net]	1035.85	1331.11	1307.01	995.46	817.28
Other Operating Revenues	15.51	9.22	13.21	14.25	16.51
Total Operating Revenues	1051.35	1340.33	1320.22	1009.72	833.79

Other Income	61.91	46.36	92.38	14.24	18.12
Total Revenue	1113.26	1386.69	1412.60	1023.96	851.91

EXPENSES
Cost Of Materials Consumed	265.88	430.08	459.46	310.32	240.24
Operating And Direct Expenses	133.48	176.29	173.19	122.73	105.75
Changes In Inventories Of FG,WIP And Stock-In Trade	49.16	-20.94	-60.35	-8.37	-11.05
Employee Benefit Expenses	135.92	110.51	100.48	87.29	73.72
Finance Costs	7.45	5.44	6.23	9.14	23.07
Depreciation And Amortisation Expenses	54.60	47.73	39.10	31.64	23.86
Other Expenses	61.11	77.86	68.02	57.27	40.02
Total Expenses	707.59	826.96	786.12	610.02	495.61

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	405.67	559.73	626.48	413.94	356.30

Profit/Loss Before Tax	405.67	559.73	626.48	413.94	356.30

Tax Expenses-Continued Operations
Current Tax	99.58	146.27	190.40	101.54	88.81
Deferred Tax	6.59	4.34	23.38	3.62	-1.30
Tax For Earlier Years	-0.78	-2.17	0.00	0.18	0.00
Total Tax Expenses	105.39	148.44	213.79	105.33	87.51
Profit/Loss After Tax And Before ExtraOrdinary Items	300.28	411.29	412.69	308.61	268.79

Profit/Loss From Continuing Operations	300.28	411.29	412.69	308.61	268.79

Profit/Loss For The Period	300.28	411.29	412.69	308.61	268.79
Share Of Profit/Loss Of Associates	0.00	0.00	41.11	53.74	48.21
Consolidated Profit/Loss After MI And Associates	300.28	411.29	453.80	362.34	317.00

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	11.80	16.16	17.83	14.23	24.91
Diluted EPS (Rs.)	11.80	16.16	17.83	14.23	24.91

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	203.65	101.83	25.46	63.64
Tax On Dividend	0.00	0.00	0.00	0.00	13.08

Cohance Lifesciences Ltd.

Balance Sheet - Consolidated

Market Cap.(`)	27579.57 Cr.	P/BV	13.94	Book Value (`)	77.71
52 Week High/Low ( ` )	1360/598	FV/ML	1/1	P/E(X)	91.85
Book Closure	09/08/2024	EPS (`)	11.80	Div Yield (%)	0.00

(` in Crs.)

You can view the Consolidated Balance Sheet for the last 5 years.

Particulars	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	1.00	1.00	1.00	1.00	1.00
No. of Equity Shares (in Lacs)	2545.65	2545.65	2545.65	2545.65	1272.82

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	25.46	25.46	25.46	25.46	12.73
Total Share Capital	25.46	25.46	25.46	25.46	12.73

Reserves and Surplus	2025.21	1709.73	1501.72	1155.35	832.03
Total Reserves and Surplus	2025.21	1709.73	1501.72	1155.35	832.03
Total Shareholders Funds	2050.66	1735.18	1527.18	1180.81	844.76

NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	4.56	28.44	35.59	91.25
Deferred Tax Liabilities [Net]	64.79	58.23	54.32	30.93	27.60
Other Long Term Liabilities	21.24	0.70	0.46	0.74	0.51
Long Term Provisions	10.50	8.30	8.89	6.65	8.31
Total Non-Current Liabilities	96.53	71.79	92.11	73.91	127.68

CURRENT LIABILITIES
Short Term Borrowings	38.58	69.53	67.13	105.64	94.04
Trade Payables	42.36	65.16	105.90	82.93	71.06
Other Current Liabilities	21.22	20.13	33.19	28.57	32.76
Short Term Provisions	4.74	3.95	4.08	2.61	2.52
Total Current Liabilities	106.90	158.77	210.29	219.75	200.37

Total Capital And Liabilities	2254.09	1965.74	1829.59	1474.47	1172.81

ASSETS
NON-CURRENT ASSETS
Tangible Assets	607.80	601.14	531.96	438.74	353.95
Intangible Assets	1.56	62.19	2.24	2.42	2.80
Capital Work-In-Progress	178.97	165.09	29.99	96.15	101.71
Intangible Assets Under Development	0.11	0.00	0.00	0.17	0.00
Fixed Assets	788.44	828.42	564.19	537.48	458.45
Goodwill On Consolidation	60.26	0.00	0.00	0.00	0.00
Non-Current Investments	130.58	117.10	117.10	361.19	307.46
Long Term Loans And Advances	0.01	0.02	0.07	0.06	0.06
Other Non-Current Assets	11.61	9.16	20.30	10.94	15.20
Total Non-Current Assets	990.90	954.70	701.66	909.68	781.16


CURRENT ASSETS
Current Investments	773.90	418.94	481.22	180.59	30.67
Inventories	231.20	312.81	283.42	201.08	174.87
Trade Receivables	133.66	110.94	236.37	102.38	117.20
Cash And Cash Equivalents	50.50	68.01	47.31	9.65	14.08
Short Term Loans And Advances	0.83	0.19	0.19	0.22	0.20
OtherCurrentAssets	73.11	100.15	79.43	70.86	54.63
Total Current Assets	1263.19	1011.05	1127.93	564.79	391.65

Total Assets	2254.09	1965.74	1829.59	1474.47	1172.81

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	56.30	40.43	29.38	47.70	78.83

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	130.58	117.10	117.10	361.19	307.46

CURRENT INVESTMENTS
Current Investments Quoted Market Value	773.90	377.90	0.00	0.00	0.00
Current Investments Unquoted Book Value	0.00	41.03	481.22	180.59	30.67

Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. | "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI : https://scores.gov.in/scores/Welcome.html

Share Wealth

Cohance Lifesciences Ltd.

Income Statement - Consolidated

Cohance Lifesciences Ltd.

Balance Sheet - Consolidated